Angela Ragazzini

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool.

How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool.

Journal: JCO oncology practice

Published: September 16, 2020

Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.

Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.

Journal: European radiology

Published: May 31, 2017

Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial.

Impact of second-line cetuximab-containing therapy in patients with KRAS wild-type metastatic colorectal cancer: results from the ITACa randomized clinical trial.

Journal: Scientific reports

Published: March 30, 2017

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab.

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab.

Journal: Scientific reports

Published: October 07, 2016

Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?

Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?

Journal: International journal of molecular sciences

Published: October 17, 2014

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial.

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 14, 2014

Taxanes as a risk factor for acute adverse reactions to iodinated contrast media in cancer patients.

Taxanes as a risk factor for acute adverse reactions to iodinated contrast media in cancer patients.

Journal: The oncologist

Published: July 27, 2014

Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?

Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?

Journal: BMC cancer

Published: July 02, 2014

KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).

KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).

Journal: PloS one

Published: November 26, 2013

Hemangioblastoma of the gastrointestinal tract: a first case.

Hemangioblastoma of the gastrointestinal tract: a first case.

Journal: International journal of surgical pathology

Published: March 22, 2013

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.

Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs.

Journal: Cancer letters

Published: November 27, 2012

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.

Journal: Journal of translational medicine

Published: January 17, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026